Conference Coverage

Complete Conference Coverage

Perioperative Gabapentin May Improve Pain Management in Head and Neck Cancer

Perioperative Gabapentin May Improve Pain Management in Head and Neck Cancer

The total morphine equivalents used were, however, not significantly different between arms.

ACA Decreased Non-Insurance Rates Among Patients With Head and Neck Cancer

ACA Decreased Non-Insurance Rates Among Patients With Head and Neck Cancer

These findings were, however, significant only in states that expanded Medicaid eligibility.

Acetaminophen May Decrease Opioid Use After Head and Neck Cancer Surgery

Acetaminophen May Decrease Opioid Use After Head and Neck Cancer Surgery

The number of PCA attempts did not differ between treatment arms.

SLNBs Feasible After Wide Local Excisions in Melanoma of the Head and Neck

SLNBs Feasible After Wide Local Excisions in Melanoma of the Head and Neck

Sentinel nodes were accurately identified in all 30 patients who underwent WLE.

Adjuvant Chemoradiotherapy Improves 5-Year OS in Salivary Squamous Cell Carcinoma

Adjuvant Chemoradiotherapy Improves 5-Year OS in Salivary Squamous Cell Carcinoma

Approximately 50% and 30% of patients with late- and early-stage disease, respectively, undergo surgery without adjuvant therapy.

Adjuvant Radiation May Improve Survival in Head and Neck Cancer

Adjuvant Radiation May Improve Survival in Head and Neck Cancer

The benefit of adjuvant radiotherapy in this setting was previously unestablished.

Celecoxib Reduces Opioid Use After Surgery in Head and Neck Cancer

Celecoxib Reduces Opioid Use After Surgery in Head and Neck Cancer

The mean total opioid morphine equivalent use in the celecoxib arm was 31.8 mg vs 45 mg in the control arm.

BLU-667 Promising in RET-Altered Solid Tumors

BLU-667 Promising in RET-Altered Solid Tumors

Doses of at least 60 mg yielded tumor reductions of 2% to 70% among 25 of the 30 evaluated patients.

Olaparib May Not Improve Overall Survival vs Chemotherapy in Breast Cancer

Olaparib May Not Improve Overall Survival vs Chemotherapy in Breast Cancer

At the time of final analysis, 192 of 302 patients had died.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs